P2X7 receptor expression was assessed in ovarian cancer cells: OVCAR3, OVCAR5, and SKOV3 and the breast cancer cell line MDA‐MB‐231 used as positive control20 with an anti‐P2X7 antibody using immunofluorescence. Here, P2RX7 is linked to breast carcinoma.